PM
Paul Mischel, M.D.
Institute Scholar, ChEM-H; Vice Chair of Research and Professor, Dept of Pathology, Stanford University; Chairman of the Scientific Advisory Board
Boundless BioTherapeutic Areas
Boundless Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ecDTx Pipeline (Lead Candidate) | Oncogene-amplified solid tumors | Phase 1 |
| ecDTx Pipeline | Oncogene-amplified solid tumors | Pre-clinical |
Leadership Team at Boundless Bio
ZH
Zachary Hornby
CEO, President, and Director
DR
Dr. Robert Doebele, M.D., Ph.D.
Chief Medical Officer
AP
Angela Pietrofeso
Vice President, Clinical Operations
AB
Amy Berkley, Ph.D.
Senior Vice President, Program Team Leadership
CH
Chris Hassig, Ph.D.
Chief Scientific Officer
DH
David Hinkle
Senior Vice President, Finance & Controller
JO
Jessica Oien
Chief Legal Officer
MW
Meredith Wesley
Chief Human Resources Officer
J“
James “Jamie” Christensen, Ph.D.
Director
NW
Nancy Whiting, Pharm.D.
Director